The role and potential mechanisms of LncRNA-TATDN1 on metastasis and invasion of non-small cell lung cancer

Oncotarget

Volumn 7, Issue 14, 2016, Pages 18219-18228

  Zequn, Niu ^a   Xuemei, Zhang ^b   Wei, Li ^a   Zongjuan, Ming ^a   Yujie, Zhong ^a   Yanli, Hou ^a   Yuping, Zhang ^a   Xia, Meng ^a   Wei, Wang ^a   Wenjing, Deng ^a   Na, Fan ^a   Shuanying, Yang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Tongji University   (China)

Author keywords

Invasion; LncRNA; Metastasis; Non small cell lung cancer; TATDN1

Indexed keywords

BETA CATENIN; DEOXYRIBONUCLEASE; EZRIN; LONG UNTRANSLATED RNA; PROTEIN TATDN1; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; CYTOSKELETON PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; LONG NON-CODING RNA TATDN1, HUMAN; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER PROGNOSIS; CELL ADHESION; CELL INVASION; CELL MOTION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE; GENE SILENCING; HER2 GENE; HIGH THROUGHPUT SCREENING; MALE; METASTASIS; METASTASIS INHIBITION; MIGRATION INHIBITION; MOUSE; NM23 H1 GENE; NON SMALL CELL LUNG CANCER; NONHUMAN; PROTEIN EXPRESSION; TUMOR INVASION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

ANIMALS; BETA CATENIN; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; RECEPTOR, ERBB-2; RNA INTERFERENCE; RNA, LONG NONCODING; RNA, SMALL INTERFERING;

EID: 84975466318     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.7788     Document Type: Article

References (38)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global Cancer Statistics. CA Cancer J Clin. 2011; 61:69-90
2. Goldstraw P, Ball D, Jett JR, Le Chevalier T, Lim E, Nicholson AG, Shepherd FA. Non small cell lung cancer. Lancet. 2011; 378:1727-1740
3. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011:the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011; 61:212-236
4. Pao W, Girard N. New driver mutations in non small cell lung cancer. Lancet Oncol. 2011; 12:175-180
5. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F, Xue C, Marinov GK, Khatun J, et al. Landscape of transcription in human cells. Nature. 2012; 489:101-108
6. Mehler MF, Mattick JS. Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. Physiol Rev. 2007; 87:799-823
7. Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet. 2006; 15:R17-R29
8. Mercer TR, Dinger ME, Sunkin SM, Mehler MF, Mattick JS. Specific expression of long noncoding RNAs in the mouse brain. ProcNatl AcadSciUSA. 2008; 105:716-721
9. Ravasi T, Suzuki H, Pang KC, Katayama S, Furuno M, Okunishi R, Fukuda S, Ru K, Frith MC, Gongora MM, Grimmond SM, Hume DA, Hayashizaki Y, et al. Experimental validation of the regulated expression of large numbers of non-coding RNAs from the mouse genome. Genome Res. 2006; 16:11-19
10. Hutchinson JN, Ensminger AW, Clemson CM, Lynch CR, Lawrence JB, Chess A. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics. 2007; 8:39
11. Clemson CM, Hutchinson JN, Sara SA, Ensminger AW, Fox AH, Chess A, Lawrence JB. An architectural role for a nuclear noncoding RNA:NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell. 2009; 33:717-726
12. Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs:functional surprises from the RNA world. Genes Dev. 2009; 23:1494-1504
13. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009; 136:629-641
14. Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, Chen N, Sun F, Fan Q. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010; 38:5366-5383
15. Beltran M, Puig I, Pena C, Garcia JM, Alvarez AB, Peña R, Bonilla F, de Herreros AG. A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition. Genes Dev. 2008; 22:756-769
16. Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, Miyano S, Mori M. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011; 71:6320-6326
17. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, Chang HY. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007; 129:1311-1323
18. Zhao J, Sun BK, Erwin JA, Song JJ, Lee JT. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science. 2008; 322:750-756
19. Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011; 10:38
20. Ji P, Diederichs S, Wang W, Boing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, Thomas M, Berdel WE, Serve H. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003; 22:8031-8041
21. Thai P, Statt S, Chen CH, Liang E, Campbell C, Wu R. Characterization of a novel long noncoding RNA, SCAL1, induced by cigarette smoke and elevated in lung cancer cell lines. Am J. Respir Cell Mol Biol. 2013; 49:204-211
22. Yang Y, Li H, Hou S, Hu B, Liu J, Wang J. The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non small cell lung cancer cell. PLoS One. 2013; 8:e65309
23. Han L, Kong R, Yin DD, Zhang EB, Xu TP, De W, Shu YQ. Low expression of long noncoding RNA GAS6-AS1 predicts a poor prognosis in patients with NSCLC. Med Oncol. 2013; 30:694
24. Charalabopoulos K, Gogali A, Kostoula OK, Constantopoulos SH. Cadherin superfamily of adhesion molecules in primary lung cancer. Exp Oncol. 2004; 26:256-260
25. Toyoyama H, Nuruki K, Ogawa H, Yanagi M, Matsumoto H, Nishijima H, Shimotakahara T, Aikou T, Ozawa M. The reduced expression of e-cadherin, a-catenin and g-catenin but not β-catenin in human lung cancer. Oncol Rep. 1999; 6:81-85
26. Rinker-Schaeffer CW, O'Keefe JP, Welch DR, Theodorescu D. Metastasis suppressor proteins:discovery, molecular mechanisms, and clinical application. Clin Cancer Res. 2006; 12:3882-3889
27. Mehner C, Hockla A, Miller E, Ran S, Radisky DC, Radisky ES. Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer. Oncotarget. 2014; 5:2736-2749. doi:10.18632/oncotarget.3229
28. Kren L, Hermanova M, Goncharuk VN, Kaur P, Ross JS, Pavlovskỳ Z, Dvorák K. Downregulation of plasma membrane expression/cytoplasmic accumulation of betacatenin predicts shortened survival in non-small cell lung cancer. A clinicopathologic study of 100 cases. Cesk Patol. 2003; 39:17-20
29. Li Q, Gao H, Xu H, Wang X, Pan Y, Hao F, Qiu X, Stoecker M, Wang E, Wang E. Expression of ezrin correlates with malignantphenotype of lung cancer, and in vitro knockdown of ezrin reverses the aggressive biological behavior of lung cancer cells. Tumour Biol. 2012; 33:1493-1504
30. Chiang AC, Massague J. Molecular basis of metastasis. N Engl Med. 2008; 359:2814-2823
31. Schmidt LH, Spieker T, Koschmieder S, Schaffers S, Humberg J, Jungen D, Bulk E, Hascher A, Wittmer D, Marra A, Hillejan L, Wiebe K, Berdel WE, et al. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth. J Thorac Oncol. 2011; 6:1984-1992
32. Meyer T, Hart IR. Mechanisms of tumour metastasis. Eur J Cancer. 1998; 34:214-221
33. Patel LR, Camacho DF, Shiozawa Y, Pienta KJ, Taichman RS. Mechanisms of cancer cell metastasis to the bone:a multistep process. Future Oncol. 2011; 7:1285-1297
34. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 1998; 392:190-193
35. Vaughan AE, Halbert CL, Wootton SK, Miller AD. Lung cancer in mice induced by the jaagsiekte sheep retrovirus envelope protein is not maintained by rare cancerstem cells, but tumorigenicity does correlate with Wnt pathway activation. Mol Cancer Res. 2012; 10:86-95
36. Sidhu SS, Nawroth R, Retz M, Lemjabbar-Alaoui H, Dasari V, Basbaum C. EMMPRIN regulates the canonical Wnt/beta-catenin signaling pathway, a potential role in accelerating lung tumorigenesis. Oncogene. 2010; 29:4145-4156
37. Li Q, Wu M, Wang H, Xu G, Zhu T, Zhang Y, Liu P, Song A, Gang C, Han Z, Zhou J, Meng L, Lu Y, et al. Ezrin silencingby small hairpin RNA reverses metastatic behaviors of human breast cancer cells. Cancer Lett. 2008; 261:55-63
38. Louvet-ValleeS. ERM proteins:from cellular architecture to cell signaling. Biol Cell. 2000; 92:305-316